Epi One logo — Taking Cancer Diagnosis to the Next Level

Epi One

Taking Cancer Diagnosis to the Next Level

Founded 2016 United States Brooklyn, United States 3 employees Angel Total: $3.10M Biotechnology, Health Care

General Information

Company Name Epi One
Founded Year 2016
Location United States Brooklyn, United States
Founders / Decision Makers
Team member Team member
Employees 3
Industries Biotechnology, Health Care
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with Epi One. To contact Epi One, visit epi-one.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Epi One compare?

A PDF of Epi One and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Epi One soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Epi One

Epi One, Inc. is a biotechnology startup based in the United States, focused on revolutionizing cancer diagnosis. Founded in 2016, the company's mission revolves around addressing the significant challenge of early cancer prognosis, detection, and the prediction of post-diagnosis drug response. Epi One, Inc. aims to leverage advanced technology to elevate cancer diagnosis to the next level. Recently, the company received a $1.00M Angel Round investment on 08 March 2024. With a strong focus on biotechnology and healthcare, Epi One, Inc. is making strides in the critical fight against cancer, positioning itself as a significant player in the industry.

Business keywords: cancer diagnosis, early prognosis, detection technology, precision medicine, drug response prediction

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round $1.00M -
06 May 2024
Angel Round $1.00M -
08 Mar 2024
Angel Round $1.10M -
30 Sep 2017

Epi One Alternatives & Competitors

View All Alternatives
Epi One vs

Addressing a critical need to find cancer early and treat cancer at the cellular level.

Post-IPO Equity
22 employees
Biotechnology, Health Care
Epi One vs

Pioneering early cancer diagnosis through advanced fluid biopsy technology

Series A
11-50 employees
Biotechnology, Health Care
Epi One vs
Exai Bio
Exai Bio United States

Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cance...

22 employees
Biotechnology, Health Care

FAQ About Epi One

Taking Cancer Diagnosis to the Next Level
Epi One was founded in 2016.
Epi One is headquartered in Brooklyn, United States.
Epi One operates in Biotechnology and Health Care. Its work centres on cancer diagnosis, early prognosis, detection technology and precision medicine.
Epi One has approximately 3 employees.
Epi One has completed 3 funding rounds, raising a total of $3.10M. The latest funding stage is Angel.
Top alternatives and competitors to Epi One include bioAffinity Technologies, ARNA Genomics, Exai Bio, Epify BV, CCG.ai (acquired by Dante Labs). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epi One and bioAffinity Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Epi One, https://bouncewatch.com/company/epi-one-inc, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes